Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoprotegerin and bone density.

D Stejskal1, M Zurek, J Bartek

  • 1Department of Laboratory Medicine, Hospital Sternberk, Czech Republic, Jívavská 20, 785 16.

Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
|November 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of Spin-Interference Effects in Exclusive J/ψ→e^{+}e^{-} Photoproduction in Ultraperipheral Heavy-Ion Collisions.

Physical review letters·2026
Same author

First Experimental Limit on the Permanent Electric Dipole Moment of the Deuteron.

Physical review letters·2026
Same author

First Observation of Deuteron-Λ Correlations at RHIC.

Physical review letters·2026
Same author

Management of chronic subdural hematoma: a consensus statement from the 2024 Copenhagen joint iCORIC/DACSUHS symposium.

Acta neurochirurgica·2026
Same author

Observation of Charmonium Sequential Suppression in Heavy-Ion Collisions at the Relativistic Heavy Ion Collider.

Physical review letters·2026
Same author

Energy Independence of the Collins Asymmetry in p^{↑}p Collisions.

Physical review letters·2026

Higher osteoprotegerin (OPG) levels correlate with reduced bone density in adults. Measuring OPG may help identify individuals with osteopenia or osteoporosis, aiding in early diagnosis and intervention for bone health.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Gerontology

Background:

  • Bone mass density (BMD) is a critical indicator of skeletal health.
  • Osteopenia and osteoporosis represent significant public health challenges, particularly in aging populations.
  • Osteoprotegerin (OPG) is a key regulator of bone resorption.

Purpose of the Study:

  • To investigate the relationship between serum osteoprotegerin (OPG) concentrations and bone mass density (BMD).
  • To determine if OPG levels can differentiate individuals with normal BMD from those with reduced bone density.

Main Methods:

  • Cross-sectional study involving 199 patients with a mean age of 63 years.
  • Bone mineral density assessed using T-scores.
  • Serum osteoprotegerin (OPG) levels measured and analyzed in relation to BMD categories.

Related Experiment Videos

Main Results:

  • Patients with osteopenia or osteoporosis (T < -1) exhibited higher median OPG levels (73 ng/l) compared to those with normal BMD (T > -1 and < 1) (60.8 ng/l).
  • A significant inverse correlation (r = -0.31) was observed between OPG concentrations and bone density values.
  • An OPG cut-off of 128 ng/l was identified for distinguishing reduced bone density.

Conclusions:

  • Serum osteoprotegerin levels are inversely associated with bone mineral density.
  • OPG determination shows potential as a biomarker for identifying individuals with diminished bone density.
  • Further research could explore OPG's role in the early detection and management of osteoporosis.